​This report provides the annual update for immunisation rates for children and adults in Jersey

In 2018:

• uptake for 1 year olds of the following were at or above the World Health Organisation (WHO) recommended national target of 95%
• 6-in-1 vaccine (96%) which protects children against diphtheria, tetanus, pertussis, polio, Haemophilus influenza type B and hepatitis B (DTaP/IPV/Hib/HepB)
• pneumococcal conjugate vaccine (PCV) (96%)
• infant meningitis B (MenB) vaccine (95%)
• uptake for 2 year olds of the following were at or above the World Health Organisation (WHO) recommended national target of 95%
• 5-in-1 (DTaP/IPV/Hib) vaccine (98%)
• first dose of the measles, mumps and rubella (MMR) (96%)
• Haemophilus influenza type B/Meningitis C (Hib/MenC) vaccine (96%)
• pneumococcal conjugate vaccine (PCV) (96%)
• infant meningitis B (MenB) vaccine (96%); uptake of the MenB booster vaccine by 24 months is reported for the first time this year
• for 5 year olds, uptake for the first dose of MMR (97%) and the Hib/MenC (95%) were at or above the 95% WHO recommendation; the 4-in-1 diphtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTaP/IPV) uptake was 94%; the uptake for the full course of MMR (two doses) by 5 years old was 93%
• 80% of eligible females (aged 12 to 13 years) received the full course of the human papillomavirus vaccine (HPV)
• over half (55%) of the birth cohort who became eligible on their 70th birthday received the shingles vaccine, a significantly higher proportion compared to England, Scotland and Wales

Immunisation Report 2018